Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Aliou Thiongane et al.|The Lancet Infectious Diseases|2020Cited by 76
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Samba O. Sow et al.|The Lancet Infectious Diseases|2020Cited by 65